Infographic

How Pharma Companies Can Gain an Edge with M&A

As dealmaking becomes more competitive and expensive, the margin for error is shrinking. Companies need to double down on M&A fundamentals.

By Kai Grass, Sarwar Islam, Floriane Haas-Falanga, and Andy Pasternak

Why there’s more pressure to make deals that create value.

I want to talk to your experts in: Please select an industry from the dropdown list

We work with ambitious leaders who want to define the future, not hide from it. Together, we achieve extraordinary outcomes.

Your email Please enter a valid email address